NuVasive’s Cervical and International Sales Drive 2022 Growth

NuVasive reported 4Q22 orthopedic sales of $305.4 million, +1.1% compared to 4Q21. For the full-year, the company generated $1.2 billion in orthopedic sales, representing 5.5% reported growth and 8.5% constant currency growth.

The company's cervical sales grew more than 20% for the fifth straight quarter. The Simplify disc "exceeded...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us